Cascade Bioscience

Flexion Therapeutics Inc, based in Burlington, MA, is at the forefront of transforming pain management through the development of precise, targeted non-opioid therapies aimed at improving the lives of patients suffering from chronic, postsurgical, and musculoskeletal pain. The company is dedicated to addressing unmet medical needs by researching advanced therapies, including innovative gene therapy solutions. Committed to meaningful change, Flexion Therapeutics emphasizes education and advocacy to enhance patient care and expand access to safe and effective non-opioid treatments. Their team is united by a passion for excellence and a dedication to making a real impact in the field of pain management. Generated from the website

Cequent Pharmaceuticals, a privately held biopharmaceutical company based in Cambridge, Massachusetts, is at the forefront of developing novel therapeutics aimed at preventing and treating a variety of human diseases, including inflammatory diseases and cancer. Established in 2006, the company leverages its proprietary TransKingdom RNA interference (tkRNAi) technology to target specific disease-causing genes safely and effectively using non-pathogenic bacteria as delivery vehicles. The tkRNAi platform enables the development of drug candidates that can silence one or more cellular genes simultaneously, offering a powerful alternative to traditional small molecules and monoclonal antibodies. With its foundation rooted in groundbreaking scientific research from the Institut Pasteur in Paris and Beth Israel Deaconess Medical Center at Harvard Medical School, Cequent is poised to make significant advancements in the biopharmaceutical landscape. Generated from the website

Revolution Medicines is a biotechnology company based in Redwood City, CA, dedicated to outsmarting cancer through innovative research and development. With a robust pipeline and cutting-edge science, Revolution Medicines is at the forefront of revolutionizing cancer treatment.Generated from the website